Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia

Prostacyclin, a potent, naturally occurring prostaglandin exerts a variety of cardiovascular and cellular actions of potential value in acute myocardial ischemia. These properties include the reduction of systemic blood pressure without changing heart rate, the lowering of coronary vascular and tota...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 1978-04, Vol.200 (4337), p.52-54
Hauptverfasser: Lefer, Allan M., Ogletree, Martin L., Smith, J. Bryan, Silver, Melvin J., Nicolaou, Kyriacos C., Barnette, William E., Gasic, Gregory P.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 54
container_issue 4337
container_start_page 52
container_title Science (American Association for the Advancement of Science)
container_volume 200
creator Lefer, Allan M.
Ogletree, Martin L.
Smith, J. Bryan
Silver, Melvin J.
Nicolaou, Kyriacos C.
Barnette, William E.
Gasic, Gregory P.
description Prostacyclin, a potent, naturally occurring prostaglandin exerts a variety of cardiovascular and cellular actions of potential value in acute myocardial ischemia. These properties include the reduction of systemic blood pressure without changing heart rate, the lowering of coronary vascular and total peripheral resistance, the inhibition of platelet aggregation and the concomitant formation of thromboxane B$_{2}$, and the reduction of the release of lysosomal enzymes.
doi_str_mv 10.1126/science.345441
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_83852210</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>1745464</jstor_id><sourcerecordid>1745464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-90b1774f841552ff566fca8990e1ac4f6314f94f419987df094882920b628a503</originalsourceid><addsrcrecordid>eNpdkDtPwzAURi3EqxRWJgZPbCl2bCc2W1XxkoroUFgjx71uXeVR7AQp_55UqQAxXel-537SPQhdUzKhNE7ugnFQGZgwLjinR2hEiRKRigk7RiNCWBJJkopzdBHClpA-U-wMnQ70CG0Wvg6NNp0pXHWPp3hRN1A1ThdFhz900eq8ADxd9ztsa48XHgL4L1et8WtXG-1XPYqXLoQWsKvw1LQN_I1egtlA6fQlOrG6CHB1mGP0_viwnD1H87enl9l0HhlORBMpktM05VZyKkRsrUgSa7RUigDVhtuEUW4Vt5wqJdOVJYpLGfff5kkstSBsjG6H3p2vP1sITVa6YKAodAV1GzLJpIhjugcnA2h6A8GDzXbeldp3GSXZ3mx2MJsNrvqDm0Nzm5ew-sH_x9vQ1P63LO3jhLNv6cZ-mA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>83852210</pqid></control><display><type>article</type><title>Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>Science Magazine</source><creator>Lefer, Allan M. ; Ogletree, Martin L. ; Smith, J. Bryan ; Silver, Melvin J. ; Nicolaou, Kyriacos C. ; Barnette, William E. ; Gasic, Gregory P.</creator><creatorcontrib>Lefer, Allan M. ; Ogletree, Martin L. ; Smith, J. Bryan ; Silver, Melvin J. ; Nicolaou, Kyriacos C. ; Barnette, William E. ; Gasic, Gregory P.</creatorcontrib><description>Prostacyclin, a potent, naturally occurring prostaglandin exerts a variety of cardiovascular and cellular actions of potential value in acute myocardial ischemia. These properties include the reduction of systemic blood pressure without changing heart rate, the lowering of coronary vascular and total peripheral resistance, the inhibition of platelet aggregation and the concomitant formation of thromboxane B$_{2}$, and the reduction of the release of lysosomal enzymes.</description><identifier>ISSN: 0036-8075</identifier><identifier>EISSN: 1095-9203</identifier><identifier>DOI: 10.1126/science.345441</identifier><identifier>PMID: 345441</identifier><language>eng</language><publisher>United States: American Association for the Advancement of Science</publisher><subject>Animals ; Blood pressure ; Blood Pressure - drug effects ; Cats ; Coronary Circulation - drug effects ; Coronary Disease - drug therapy ; Epoprostenol - pharmacology ; Epoprostenol - therapeutic use ; Heart rate ; Heart Rate - drug effects ; Hemodynamics - drug effects ; In Vitro Techniques ; Lysosomes - drug effects ; Lysosomes - enzymology ; Myocardial Contraction - drug effects ; Myocardial ischemia ; Perfusion ; Platelet aggregation ; Platelet Aggregation - drug effects ; Prostaglandins ; Prostaglandins - pharmacology ; Thromboxanes ; Thromboxanes - blood ; Vascular resistance ; Vascular Resistance - drug effects ; Vasodilation ; Vehicles</subject><ispartof>Science (American Association for the Advancement of Science), 1978-04, Vol.200 (4337), p.52-54</ispartof><rights>Copyright 1978 American Association for the Advancement of Science</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-90b1774f841552ff566fca8990e1ac4f6314f94f419987df094882920b628a503</citedby><cites>FETCH-LOGICAL-c405t-90b1774f841552ff566fca8990e1ac4f6314f94f419987df094882920b628a503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/1745464$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/1745464$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,2871,2872,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/345441$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lefer, Allan M.</creatorcontrib><creatorcontrib>Ogletree, Martin L.</creatorcontrib><creatorcontrib>Smith, J. Bryan</creatorcontrib><creatorcontrib>Silver, Melvin J.</creatorcontrib><creatorcontrib>Nicolaou, Kyriacos C.</creatorcontrib><creatorcontrib>Barnette, William E.</creatorcontrib><creatorcontrib>Gasic, Gregory P.</creatorcontrib><title>Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia</title><title>Science (American Association for the Advancement of Science)</title><addtitle>Science</addtitle><description>Prostacyclin, a potent, naturally occurring prostaglandin exerts a variety of cardiovascular and cellular actions of potential value in acute myocardial ischemia. These properties include the reduction of systemic blood pressure without changing heart rate, the lowering of coronary vascular and total peripheral resistance, the inhibition of platelet aggregation and the concomitant formation of thromboxane B$_{2}$, and the reduction of the release of lysosomal enzymes.</description><subject>Animals</subject><subject>Blood pressure</subject><subject>Blood Pressure - drug effects</subject><subject>Cats</subject><subject>Coronary Circulation - drug effects</subject><subject>Coronary Disease - drug therapy</subject><subject>Epoprostenol - pharmacology</subject><subject>Epoprostenol - therapeutic use</subject><subject>Heart rate</subject><subject>Heart Rate - drug effects</subject><subject>Hemodynamics - drug effects</subject><subject>In Vitro Techniques</subject><subject>Lysosomes - drug effects</subject><subject>Lysosomes - enzymology</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocardial ischemia</subject><subject>Perfusion</subject><subject>Platelet aggregation</subject><subject>Platelet Aggregation - drug effects</subject><subject>Prostaglandins</subject><subject>Prostaglandins - pharmacology</subject><subject>Thromboxanes</subject><subject>Thromboxanes - blood</subject><subject>Vascular resistance</subject><subject>Vascular Resistance - drug effects</subject><subject>Vasodilation</subject><subject>Vehicles</subject><issn>0036-8075</issn><issn>1095-9203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1978</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkDtPwzAURi3EqxRWJgZPbCl2bCc2W1XxkoroUFgjx71uXeVR7AQp_55UqQAxXel-537SPQhdUzKhNE7ugnFQGZgwLjinR2hEiRKRigk7RiNCWBJJkopzdBHClpA-U-wMnQ70CG0Wvg6NNp0pXHWPp3hRN1A1ThdFhz900eq8ADxd9ztsa48XHgL4L1et8WtXG-1XPYqXLoQWsKvw1LQN_I1egtlA6fQlOrG6CHB1mGP0_viwnD1H87enl9l0HhlORBMpktM05VZyKkRsrUgSa7RUigDVhtuEUW4Vt5wqJdOVJYpLGfff5kkstSBsjG6H3p2vP1sITVa6YKAodAV1GzLJpIhjugcnA2h6A8GDzXbeldp3GSXZ3mx2MJsNrvqDm0Nzm5ew-sH_x9vQ1P63LO3jhLNv6cZ-mA</recordid><startdate>19780407</startdate><enddate>19780407</enddate><creator>Lefer, Allan M.</creator><creator>Ogletree, Martin L.</creator><creator>Smith, J. Bryan</creator><creator>Silver, Melvin J.</creator><creator>Nicolaou, Kyriacos C.</creator><creator>Barnette, William E.</creator><creator>Gasic, Gregory P.</creator><general>American Association for the Advancement of Science</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19780407</creationdate><title>Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia</title><author>Lefer, Allan M. ; Ogletree, Martin L. ; Smith, J. Bryan ; Silver, Melvin J. ; Nicolaou, Kyriacos C. ; Barnette, William E. ; Gasic, Gregory P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-90b1774f841552ff566fca8990e1ac4f6314f94f419987df094882920b628a503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1978</creationdate><topic>Animals</topic><topic>Blood pressure</topic><topic>Blood Pressure - drug effects</topic><topic>Cats</topic><topic>Coronary Circulation - drug effects</topic><topic>Coronary Disease - drug therapy</topic><topic>Epoprostenol - pharmacology</topic><topic>Epoprostenol - therapeutic use</topic><topic>Heart rate</topic><topic>Heart Rate - drug effects</topic><topic>Hemodynamics - drug effects</topic><topic>In Vitro Techniques</topic><topic>Lysosomes - drug effects</topic><topic>Lysosomes - enzymology</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocardial ischemia</topic><topic>Perfusion</topic><topic>Platelet aggregation</topic><topic>Platelet Aggregation - drug effects</topic><topic>Prostaglandins</topic><topic>Prostaglandins - pharmacology</topic><topic>Thromboxanes</topic><topic>Thromboxanes - blood</topic><topic>Vascular resistance</topic><topic>Vascular Resistance - drug effects</topic><topic>Vasodilation</topic><topic>Vehicles</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lefer, Allan M.</creatorcontrib><creatorcontrib>Ogletree, Martin L.</creatorcontrib><creatorcontrib>Smith, J. Bryan</creatorcontrib><creatorcontrib>Silver, Melvin J.</creatorcontrib><creatorcontrib>Nicolaou, Kyriacos C.</creatorcontrib><creatorcontrib>Barnette, William E.</creatorcontrib><creatorcontrib>Gasic, Gregory P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Science (American Association for the Advancement of Science)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lefer, Allan M.</au><au>Ogletree, Martin L.</au><au>Smith, J. Bryan</au><au>Silver, Melvin J.</au><au>Nicolaou, Kyriacos C.</au><au>Barnette, William E.</au><au>Gasic, Gregory P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia</atitle><jtitle>Science (American Association for the Advancement of Science)</jtitle><addtitle>Science</addtitle><date>1978-04-07</date><risdate>1978</risdate><volume>200</volume><issue>4337</issue><spage>52</spage><epage>54</epage><pages>52-54</pages><issn>0036-8075</issn><eissn>1095-9203</eissn><abstract>Prostacyclin, a potent, naturally occurring prostaglandin exerts a variety of cardiovascular and cellular actions of potential value in acute myocardial ischemia. These properties include the reduction of systemic blood pressure without changing heart rate, the lowering of coronary vascular and total peripheral resistance, the inhibition of platelet aggregation and the concomitant formation of thromboxane B$_{2}$, and the reduction of the release of lysosomal enzymes.</abstract><cop>United States</cop><pub>American Association for the Advancement of Science</pub><pmid>345441</pmid><doi>10.1126/science.345441</doi><tpages>3</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-8075
ispartof Science (American Association for the Advancement of Science), 1978-04, Vol.200 (4337), p.52-54
issn 0036-8075
1095-9203
language eng
recordid cdi_proquest_miscellaneous_83852210
source Jstor Complete Legacy; MEDLINE; Science Magazine
subjects Animals
Blood pressure
Blood Pressure - drug effects
Cats
Coronary Circulation - drug effects
Coronary Disease - drug therapy
Epoprostenol - pharmacology
Epoprostenol - therapeutic use
Heart rate
Heart Rate - drug effects
Hemodynamics - drug effects
In Vitro Techniques
Lysosomes - drug effects
Lysosomes - enzymology
Myocardial Contraction - drug effects
Myocardial ischemia
Perfusion
Platelet aggregation
Platelet Aggregation - drug effects
Prostaglandins
Prostaglandins - pharmacology
Thromboxanes
Thromboxanes - blood
Vascular resistance
Vascular Resistance - drug effects
Vasodilation
Vehicles
title Prostacyclin: A Potentially Valuable Agent for Preserving Myocardial Tissue in Acute Myocardial Ischemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T10%3A09%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prostacyclin:%20A%20Potentially%20Valuable%20Agent%20for%20Preserving%20Myocardial%20Tissue%20in%20Acute%20Myocardial%20Ischemia&rft.jtitle=Science%20(American%20Association%20for%20the%20Advancement%20of%20Science)&rft.au=Lefer,%20Allan%20M.&rft.date=1978-04-07&rft.volume=200&rft.issue=4337&rft.spage=52&rft.epage=54&rft.pages=52-54&rft.issn=0036-8075&rft.eissn=1095-9203&rft_id=info:doi/10.1126/science.345441&rft_dat=%3Cjstor_proqu%3E1745464%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=83852210&rft_id=info:pmid/345441&rft_jstor_id=1745464&rfr_iscdi=true